Stéfan Halbherr

InnoMedica

Stéfan Halbherr is one of five founders of the start-up company InnoMedica and has led the Research and Development department since the beginning 4 years ago. He studied biochemistry and immunology and holds a PhD degree from the University of Berne (Switzerland).

With a dedicated team and a 22-people-strong company he aims at bridging the gap between innovative medicine and patient’s needs. He developed a unique industrial scale GMP manufacturing process for ultra-small liposomes with novel biological properties.

This process enabled the research of pipeline products that today cover the areas of nano-chemotherapy and image guided surgery in oncology, neurodegenerative diseases, and bacteriology. With the first product Talidox moving into phase 1 testing a major milestone has been achieved.

dont miss

Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration

Ultra-small liposomes of 30nm in size give rise to unknown pharmacological effects. Talidox (Targeted Liposomal Doxorubicin) accumulates chemotherapeutic drug in cancer tissue and minimizes its side effects. Using the nano-shuttle, near-infrared dye is specifically transported to tumors and can assist during fluorescence-guided surgery. Talineuren (Targeted Liposomal Neuroregenerator) delivers neuroprotective GM1 ganglioside to the brain after oral intake, thereby e.g. elevating dopamine levels in the striatum in Parkinson models of disease.

EVEN MORE SEMINARS

  • Cheng Boon: Speaking at the Oncology Convention

    Cheng Boon
    Worcestershire Royal Hospital

    Consultant Clinical Oncologist, GI and Head & Neck

  • Nizar Asadi: Speaking at the Oncology Convention

    Nizar Asadi
    Royal Brompton & Harefield NHS Foundation Trust

    Thoracic surgery in the treatment of lung cancer

  • Mohamed Torky: Speaking at the Oncology Convention

    Mohamed Torky
    Hospital Germans Trias i pujol. Barcelona. Spain

    Role of Radial-EBUS in diagnosis of lung cancer.

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Stéfan Halbherr: Speaking at the Oncology Convention

    Stéfan Halbherr
    InnoMedica

    Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration